Author

Harald Peeters 1

1 AZ Sint-Lucas Ghent,Ghent,Belgium

ACCELERATED STEP-UP APPROACH AND LONG-TERM DISEASE OUTCOMES IN PAEDIATRIC PATIENTS WITH CROHN?S DISEASE

Lucas Wauters, Françoise Smets, Ilse Hoffman, Elisabeth De Greef, Patrick Bontems, Philippe Alliet, Wim Arts, Bruno Hauser, Stephanie Van Biervliet, Els Van de Vijver, Isabelle Paquot, Harald Peeters, Peter Bossuyt, Jean François Rahier, Tom Moreels, Olivier Dewit, Denis Franchimont, Vinciane Muls, Fernand Fontaine, Edou

CHARACTERISTICS OF CHILDREN WITH CROHN?S DISEASE FAILING SUSTAINED REMISSION DESPITE ANTI-TNF EXPOSURE

Lucas Wauters, Françoise Smets, Ilse Hoffman, Elisabeth De Greef, Patrick Bontems, Philippe Alliet, Wim Arts, Bruno Hauser, Stephanie Van Biervliet, Els Van de Vijver, Isabelle Paquot, Harald Peeters, Peter Bossuyt, Jean François Rahier, Tom Moreels, Olivier Dewit, Denis Franchimont, Vinciane Muls, Fernand Fontaine, Edou

HIGHER ENDOSCOPIC AND CLINICAL REMISSION RATES WITH VEDOLIZUMAB IN EARLY THAN IN LATE CROHN’S DISEASE: RESULTS FROM THE LOVE-CD STUDY (LOW COUNTRIES VEDOLIZUMAB IN CD STUDY)

Geert R. D'Haens, Peter Bossuyt, Filip Baert, Tamás Molnár, Wouter Van Moerkercke, Esmee Clasquin, Mark Lowenberg, Nahid Mostafavi, Harald Peeters, Guy Lambrecht, Frank Hoentjen, Severine Vermeire

Integrin expression changes on the T cell subsets influence the response to vedolizumab in inflammatory bowel disease patients

Cara De Galan, Sophie Van Welden, Simon Bos, Simon Tavernier, Triana Lobaton Ortega, Gerard Gonzales, Wouter Van Moerkercke, Beatrijs Strubbe, Harald Peeters, Elisabeth Macken, Martine De Vos, Debby Laukens, Pieter Hindryckx

SAFETY OF VEDOLIZUMAB AND USTEKINUMAB IN ELDERLY IBD PATIENTS: A REAL-LIFE MULTICENTRIC COHORT STUDY

Cara De Galan, Harald Peeters, Francisco Mesonero Gismero, Marie Truyens, Ainara Elorza, Paola Torres, Liv Vandermeulen, Aranzazu Jauregui Amezaga, Rocío Ferreiro-Iglesias, Yamile Zabana, Tom Holvoet, Laia Peries Reverter, Jeroen Geldof, Triana Lobaton, Martine De Vos

ULTRAPROACTIVE THERAPEUTIC DRUG MONITORING BASED ON POINT-OF-CARE TESTING OF INFLIXIMAB IS NOT SUPERIOR TO REACTIVE DRUG MONITORING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE: 1 YEAR RESULTS OF A PRAGMATIC CLINICAL TRIAL

Peter Bossuyt, Sophie Claeys, Soetkin D'haens, Eveline Hoefkens, Beatrijs Strubbe, Denis Marichal, Lieven Pouillon, Harald Peeters

VEDOLIZUMAB IS ASSOCIATED WITH STEROID-FREE CLINICAL REMISSION AND DISCONTINUATION-FREE SURVIVAL IN PATIENTS WITH MODERATE-TO-SEVERE ULCERATIVE PROCTITIS

Pauline Lemmens, João Sabino, Edouard Louis, Wouter Van Moerkercke, Lieven Pouillon, Michaël Somers, Harald Peeters, Stijn Dr. Vanden Branden, Julie Busschaert, Filip Baert, Anneline Cremer, Philippe Potvin, Sophie Dewit, Arnaud Colard, Jo Swinnen, Guy Lambrecht, Christophe Claessens, Barbara Willandt, Pieter Dewint, Evi

Item 1 - 7 / 17
1
2